Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejectionYe Cui(Brigham and Women's Hospital), Souheil El‐Chemaly(Harvard University)Journal of Clinical InvestigationOctober 20, 201510.1172/jci79693Cited by 96SaveCiteExport RISWatch citationsRelated PapersTransforming Growth Factor-β1 Downregulates Vascular Endothelial Growth Factor-D Expression in Human Lung Fibroblasts via the Jun NH2-Terminal Kinase Signaling Pathway|Molecular Medicine|2014|43Glycogen synthase kinase 3-β inhibition induces lymphangiogenesis through β-catenin-dependent and mTOR-independent pathways|PLoS ONE|2019|14